| Cost analysis of oral hypolipidemic agents available in India VS Chawan, KV Gawand, SV Badwane Int J Basic Clin Pharmacol 3 (6), 954-7, 2014 | 25 | 2014 |
| Impact of new regulations on clinical trials in India VS Chawan, KV Gawand, AM Phatak Int J Clin Trials 2 (3), 56-58, 2015 | 18 | 2015 |
| Fluoroquinolones in India Are we prescribing it right: A cost variation study VS Chawan, KV Gawand, SV Badwane National Journal of Physiology, Pharmacy and Pharmacology 5 (4), 306-306, 1970 | 14 | 1970 |
| Analysis of price variation amongst different formulations of anxiolytic drugs available in Indian market VS Chawan, SV Badwane, KV Gawand, MU Chhaya Int J Res Med Sci 4 (6), 2398-2401, 2017 | 13 | 2017 |
| Analysis of randomized clinical trials leading to new drug approvals in India and USA VS Chawan, SV Badwane, KV Gawand, AM Phatak, MS Naik Int J Clin Trials 3 (2), 68-71, 2016 | 4 | 2016 |
| An analysis of clinical trials registered with CTRI in India from 2007 to 2015 VS Chawan, SV Badwane, KV Gawand, MU Chhaya Int J Clin Trials 3, 155, 2016 | 2 | 2016 |
| Antiepileptic drugs: newer targets and new drugs V Chawan, A Phatak, K Gawand, S Badwane, S Panchal International Journal of Basic & Clinical Pharmacology 5 (3), 587, 2016 | 1 | 2016 |
| Perspectives in pediatric clinical trials: a review VS Chawan, SV Badwane, KV Gawand, AM Phatak, SS Chaubey International Journal 3 (2), 52, 2016 | 1 | 2016 |
| Price analysis of antianginal drugs available in Indian market VS Chawan, SV Badwane, KV Gawand, MU Chhaya International Journal of Basic & Clinical Pharmacology 5 (5), 1991, 2016 | | 2016 |
| An overview of drugs approved in India from 1999 through 2015 VS Chawan, KV Gawand, AM Phatak, SV Badwane International Journal of Basic & Clinical Pharmacology 4 (4), 697, 2015 | | 2015 |
